Premium
Quality of life and oral function following radiotherapy for head and neck cancer
Author(s) -
Epstein Joel B.,
Emerton Sue,
Kolbinson Dean A.,
Le Nhu D.,
Phillips Norm,
StevensonMoore Peter,
Osoba David
Publication year - 1999
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/(sici)1097-0347(199901)21:1<1::aid-hed1>3.0.co;2-4
Subject(s) - medicine , quality of life (healthcare) , radiation therapy , head and neck cancer , dry mouth , mood , cancer , dysphagia , physical therapy , swallowing , dentistry , surgery , psychiatry , nursing , saliva
Background Multiple oral complaints occur following radiotherapy for oropharyngeal cancer, but the frequency and severity of symptoms of dysfunction and discomfort are not well understood. The purpose of this investigation was to assess the quality of life, oral function, and oral symptoms following radiotherapy. Methods A general quality of life survey (the European Organization for Research and Treatment of Cancer [EORTC] Quality of Life Questionnaire QLQ‐C30), with an added oral symptom and function scale was mailed to 100 patients more than 6 months following radiotherapy. Results Sixty‐five patients responded. Difficulty chewing or eating was reported by 43% of respondents. Dry mouth was reported by 91.8%, change in taste by 75.4%, dysphagia by 63.1%, altered speech by 50.8%, difficulty with dentures by 48.5%, and increased tooth decay by 38.5% of dentate patients. Pain was common (58.4%) and interfered with daily activities in 30.8%. Mood complaints were reported by approximately half the patients. Interference of the physical condition social activities was reported by 60%. The frequency of oral side effects correlated with radiation treatment fields and dose. Conclusion Oral complications following radiotherapy for head and neck cancer are common and affect quality of life. Use of a general function scale such as the EORTC questionnaire with the addition of disease/site specific scales may provide useful data on outcome of therapy and upon the complications associated with therapy and impact upon the quality of life. © 1999 John Wiley & Sons, Inc. Head Neck 21: 1–11, 1999.